• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,277.48 121.86
( 0.16%)
Global Indices
Nasdaq
51,515.27 -505.40
(-0.97%)
Dow Jones
7,441.22 -91.13
(-1.21%)
Hang Seng
69,975.80 571.30
(0.82%)
Nikkei 225
10,505.62 11.41
(0.11%)
Forex
USD-INR
94.55 -0.09
(-0.09%)
EUR-INR
109.66 -0.13
(-0.12%)
GBP-INR
126.84 -0.25
(-0.20%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
145.48
436666.97
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.88
 

marsons ltd
Marsons bags Rs 33-cr supply order from Vikran Engineering
Jun 10,2026
The order comprises various quantities of 17.6 MVA, 8.8 MVA and 4.4 MVA oil-cooled (ONAN), OCTC, outdoor-type, aluminum-wound inverter-duty transformers. The domestic order is scheduled to be executed within six months.

Marsons clarified that neither the promoter/promoter group nor group companies have any interest in the awarding entity, and the contract does not fall under related-party transactions.

Marsons is engaged in the business of manufacturing, trading & servicing transformers, transformer goods & other rental income. The company’s consolidated net profit surged 151.6% to Rs 22.62 crore on a 66% increase in net sales to Rs 92.65 crore in Q4 FY26 over Q4 FY25.

Shares of Marsons shed 0.61% to Rs 123 on the BSE.